EC

Emigrant Capital

North America, New York, United States, New York

Description

Emigrant Capital is the private equity division of Emigrant Bank that provides long-term equity to middle-market businesses.

Investor Profile

Emigrant Capital has made 8 investments, with 1 in the past 12 months and 25% as lead.

Stage Focus

  • Series Unknown (38%)
  • Series A (25%)
  • Series B (13%)
  • Series D (13%)
  • Seed (13%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Care
  • Medical
  • Internet
  • Pharmaceutical
  • Therapeutics
  • Apps
  • Travel
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Emigrant Capital frequently co-invest with?

Taiwania Capital Management Corporation
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
Alexandria Real Estate Equities
North America, California, United States, Pasadena
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
HP
North America, New York, United States, New York
Co-Investments: 1
Morningside Group
North America, Massachusetts, United States, Newton Center
Co-Investments: 1
Cobro Ventures
North America, Virginia, United States, Arlington
Co-Investments: 2
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
RC
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
AI
North America, New York, United States, Greenport
Co-Investments: 1
PC
North America, Massachusetts, United States, Lincoln
Co-Investments: 1

Which angels does Emigrant Capital often collaborate with?

KL
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by Emigrant Capital?

Affiniti

New York, New York, United States

Fueling Small Businesses Across America With Industry-Tailored Credit Cards.

Financial Services
SeedNov 13, 2024
Amount Raised: $11,000,000
Frequency Therapeutics

Lexington, Massachusetts, United States

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

BiotechnologyGeneticsHealth CareMedical
Series BJan 7, 2019
Amount Raised: $42,000,000
Frequency Therapeutics

Lexington, Massachusetts, United States

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

BiotechnologyGeneticsHealth CareMedical
Series AApr 11, 2017
Amount Raised: $32,000,000
GroundLink

New York, New York, United States

GroundLink is a car service where users can order a car and schedule a future ride online or through its mobile phone app.

AppsInternetTravel
Series AApr 5, 2008
Amount Raised: $20,000,000
Lev Pharmaceuticals

New York, New York, United States

Lev Pharmaceuticals is focused on developing therapeutic products for the treatment of inflammatory diseases.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownOct 23, 2006
Amount Raised: $21,000,000
Boylan Bottling

New York, New York, United States

Boylan Bottling is engaged in producing and marketing bottled sodas.

Consumer GoodsRetailShopping
Series UnknownSep 10, 2003
Intralinks

New York, New York, United States

Intralinks is a technology company that offers a range of firewall collaboration solutions.

Clinical TrialsCollaborationFile Sharing
Series UnknownFeb 8, 2001
Amount Raised: $40,000,000
RealNames

San Carlos, California, United States

RealNames is an online platform offers an internet naming solution and navigation system for internet users.

InternetNavigationSearch EngineSoftware
Series DDec 4, 2000
Amount Raised: $46,500,000